- Hong Kong stocks resume rally, oil dips after Middle East-fuelled surge
- Crude stable after Israel-Iran surge, Hong Kong stocks resume gains
- Hera spacecraft to probe asteroid deflected by defence test
- US dockworkers to head back to work after tentative deal
- After Helene's destruction, North Carolina starts to rebuild
- Dockers end three-day strike at Montreal port
- What next for OpenAI after $157 billion bonanza?
- Israel-Hamas war causes 86-percent dive in Gaza GDP: IMF
- Milan's Morata moves house after Inter-fan town mayor 'violates' privacy
- 'Devastating' storm hits Augusta National but Masters will go on
- Relief in Brazil, Asia over delay to EU deforestation rules
- Oil prices jump, stocks fall on Middle East tensions
- Biden says 'discussing' possible Israeli strikes on Iran oil facilities
- Oil prices rise, stocks fall on Middle East tensions
- Oil rallies, stocks mostly retreat on Middle East tensions
- Phasing out teen smoking could save 1.2 mn lives: study
- 'Welcome relief': Asia producers hail EU deforestation law delay
- Japan PM slated to announce plans for 'happiness index'
- Turkish inflation falls less than expected in September at 49.4%
- Easing inflation lifts profit at UK supermarket Tesco
- Skiing calls on UN climate science to combat melting future
- China wine industry looks to breed climate resilience
- Tokyo rallies on weak yen, Hong Kong drops after surge
- Dutch airline KLM unveils 'firm' cost-cutting measures
- Carpe diem: the Costa Rican women turning fish into fashion
- Senegal looks to aquaculture as fish stocks dwindle
- Will AI one day win a Nobel Prize?
- Climate change, economics muddy West's drive to curb Chinese EVs
- Argentina's Milei vetoes university budget after huge protests
- TotalEnergies plans to grow oil and gas production until 2030
- 2024 Nobels offer glimmer of hope as global crises mount
- Tokyo rallies on weak yen, Hong Kong reverses after surge
- Tunisia readies for vote as incumbent Saied eyes victory
- High childcare costs in US weigh on women's employment
- US voters seek help with crushing childcare costs
- Taiwan shuts down for second day as Typhoon Krathon to land
- Supercharged storms: how climate change amplifies cyclones
- Biden official urges talks as US port strike enters second day
- Huge protests in Argentina over public university cuts
- Rally in oil prices loses steam on mixed day for global stocks
- South America treated to rare 'ring of fire' eclipse
- Biden official says port strike deal not as far as parties think
- Mexico's new president offers apology for 1968 student massacre
- Historic funding round values OpenAI at $157 billion
- Mixed US car sales in Q3 as industry hopes for post-election bounce
- Thunderstorms are a 'boiling pot' of gamma rays, scientists find
- Scientists unlock secret of 'Girl With Pearl Earring'
- Dolphins flash friendly grins when they're ready to play
- Facing backlash, EU moves to delay deforestation rules
- US private sector adds more jobs than expected in September: ADP
CMSD | -0.16% | 24.89 | $ | |
SCS | -1.98% | 12.62 | $ | |
RBGPF | 100% | 58.93 | $ | |
CMSC | -0.16% | 24.74 | $ | |
NGG | -2.7% | 66.97 | $ | |
BCC | -0.9% | 138.29 | $ | |
GSK | -2.81% | 38.37 | $ | |
RIO | -1.42% | 69.83 | $ | |
AZN | -2.12% | 77.93 | $ | |
JRI | -0.6% | 13.3 | $ | |
RYCEF | 1.15% | 6.98 | $ | |
VOD | -0.52% | 9.69 | $ | |
RELX | -1.46% | 46.61 | $ | |
BCE | -1.77% | 33.84 | $ | |
BP | 0.28% | 32.46 | $ | |
BTI | -2.45% | 35.11 | $ |
Deal reached for generic drug to prevent HIV infection
A deal has been reached to allow for distribution of a low-cost generic version of a long-term preventative treatment against HIV in low-income countries where most of the world's infections occur, Unitaid and the Medicines Patent Pool announced Thursday.
The deal will see ViiV Healthcare, a subsidiary of British pharmaceutical giant GSK, allow selected manufacturers to produce generic versions of Cabotegravir LA, its long-acting pre-exposure prophylaxis (PrEP) treatment for HIV.
The deal will provide access to the injectable version of cabotegravir, which has been shown to provide two months of protection against infection, in 90 countries where over 70 percent of all new HIV infections occurred in 2020, said Unitaid.
"Access to an effective long-acting HIV prevention option could significantly contribute to the goal of ending HIV transmission and ending the epidemic by 2030," said Unitaid spokesman Herve Verhoosel.
"Efforts to increase access to Cabotegravir LA for PrEP will be especially impactful for groups that experience particularly high rates of infection, such as men who have sex with men and sex workers," he added.
Long-lasting cabotegravir injections only recently became available, and have been shown to be much more effective than an oral version that needed to be taken daily.
But the cost -- the price of a year's treatment cost $22,000 in the United States earlier this year -- was an obstacle for widespread rollout in all but high-income countries.
- 'Top global priority' -
The World Health Organization released new guidelines about cabotegravir on Thursday, calling for countries to work towards making the drug swiftly available for those in need.
"We hope these new guidelines will help accelerate country efforts to start to plan and deliver CAB-LA alongside other HIV prevention options," Meg Doherty, director of the WHO's global HIV, hepatitis and sexually-transmitted infection programmes, said in a statement.
The news comes one day after a new report presented at the International AIDS Conference in Montreal, Canada, that found the global fight against HIV has stalled from shrinking resources due to Covid-19 and other crises.
Some 1.5 million new infections occurred last year –- more than a million over global targets of fighting the virus.
"Long-acting PrEP could play a major role in ending the HIV pandemic, but right now, very few people can get it," said Adeeba Kamarulzaman, president of the International AIDS Society which convenes the conference.
"Scaling up affordable access to this game-changing prevention tool must be a top global priority," she said in a statement.
Unitaid is a global health initiative which works on ensuring equitable access to medical innovations in low- and middle-income countries.
The Medicines Patent Pool, founded by Unitaid and UN-backed, works to licence needed medicines for generic distribution in low- and middle-income countries.
D.Goldberg--CPN